(Q50585964)
Statements
Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection (English)
B Kallinowski
H Liehr
B Moeller
J G Wechsler
M Wiese
scientific article published in March 2001